AstraZeneca Signs $1.5B AI Drug Discovery Deal with insitro

Key Facts

1AstraZeneca signed a collaboration agreement with insitro for AI-driven drug discovery worth up to $1.5 billion in total payments.

AstraZeneca signed a collaboration agreement with insitro for AI-driven drug discovery worth up to $1.5 billion in total payments. Seeking Alpha reported that the deal structure includes upfront and milestone payments to advance the development of new medicines.

The partnership aims to accelerate drug discovery processes and improve clinical success rates by utilizing insitro's AI-driven biological modeling platforms. AstraZeneca (AZN) closed at $162.03 on October 14, 2026, having reached a session high of $162.71.